Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001224141 | SCV001396324 | uncertain significance | Deficiency of ferroxidase | 2022-06-17 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with histidine, which is basic and polar, at codon 604 of the CP protein (p.Pro604His). This variant is present in population databases (rs188643164, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with CP-related conditions. ClinVar contains an entry for this variant (Variation ID: 952095). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CP protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV004695223 | SCV005189834 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Fulgent Genetics, |
RCV001224141 | SCV005664949 | uncertain significance | Deficiency of ferroxidase | 2024-04-30 | criteria provided, single submitter | clinical testing |